Vanderbilt O'Brien Kidney Center-Administrative Core
范德比尔特奥布莱恩肾脏中心-行政核心
基本信息
- 批准号:10163163
- 负责人:
- 金额:$ 11.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAdministrative PersonnelAdvisory CommitteesAnimal WelfareBudgetsCollaborationsCommunicationCommunitiesCommunity OutreachCounselingEducationEducational workshopFacultyFundingGoalsGovernment regulationsGrantInformaticsInjury to KidneyInstitutesInternationalInternshipsInvestigationKidneyKidney DiseasesKnowledgeLeadershipMissionNational Institute of Diabetes and Digestive and Kidney DiseasesNephrologyOffice ManagementPoliciesProceduresRecording of previous eventsResearchResearch PersonnelResourcesReview CommitteeSeriesServicesTranslationsUnited States National Institutes of HealthYangmembernovel therapeutic interventionoperationoutreach programprogramsrecruitsummer internshipsummer studentsymposiumweb site
项目摘要
Abstract
The Administrative Core will oversee the Vanderbilt O'Brien Kidney Center (VOKC) mission to advance
effective translation of new therapeutic approaches to the treatment of kidney disease. The Center leadership
consists of a Director (Raymond Harris), an Associate Director (Ambra Pozzi) and Core Directors or Co-
Directors (Kerri Cavanaugh, Mark de Caestecker, Eric Delpire, Agnes Fogo, Leslie Gewin, Volker Haase,
Adriana Hung, Alp Ikizler, , Eddie Siew, Takamune Takahashi, Haichun Yang, Matthew Wilson Roy Zent and
Ming-Zhi Zhang). All of the members of the Center leadership possess the knowledge and expertise necessary
for investigation of kidney disease. In addition, the Center leaders, as well as the other key members of the
Center, have a long history of productive collaboration.
The Administrative Component is responsible for 1) determining the membership of the VOKC; 2) allocating
resources to the specific Cores; 3) overseeing the animal welfare component; 4) overseeing the Pilot and
Feasibility Program; and 5) developing long-term strategy. In association with the Education and Enrichment
Core, the Administrative Component also oversees 1) the Vanderbilt Center for Kidney Disease (VCKD)
website (www.vckd.org), which allows effective communication with Center members and the kidney disease
research community outside Vanderbilt and provides informatics support to Center-affiliated members, 2) the
workshop programs; 3) the Renal Research Conference series; 4) a biannual Nephrology retreat; 5) the
community outreach programs; and 6) the summer student internship program. Finally, in these efforts, the
Director and Center leadership will receive advice and counsel from the Internal Advisory Committee, the
External Advisory Committee and the Pilot and Feasibility Review Committee.
In summary, the Administrative Component will serve as the coordinating center of the VOKC. Its goal is to
strive to provide unique services to the community of renal researchers both locally and in the larger national
and international research community.
抽象的
行政核心将监督范德比尔特奥布莱恩肾脏中心 (VOKC) 的使命,以推进
有效转化治疗肾脏疾病的新治疗方法。中心领导
由一名董事 (Raymond Harris)、一名副董事 (Ambra Pozzi) 和核心董事或联合董事组成
导演(Kerri Cavanaugh、Mark de Caestecker、Eric Delpire、Agnes Fogo、Leslie Gewin、Volker Haase、
Adriana Hung、Alp Ikizler、Eddie Siew、Takamune Takahashi、Haichun Yang、Matthew Wilson Roy Zent 和
张明志).中心领导层的所有成员都拥有必要的知识和专业知识
用于肾脏疾病的研究。此外,中心领导以及其他主要成员
中心,有着悠久的富有成效的合作历史。
行政部门负责 1) 确定 VOKC 的成员资格; 2)分配
特定核心的资源; 3) 监督动物福利部分; 4) 监督试点和
可行性计划; 5)制定长期战略。与教育和丰富活动相关
核心行政部门还负责监督 1) 范德比尔特肾脏病中心 (VCKD)
网站(www.vckd.org),可以与中心成员和肾脏疾病进行有效沟通
范德比尔特大学以外的研究社区,并为中心附属成员提供信息学支持,2)
讲习班计划; 3)肾脏研究会议系列; 4) 每两年一次的肾内科静修会; 5) 的
社区外展计划; 6)暑期学生实习计划。最后,在这些努力中,
主任和中心领导层将接受内部咨询委员会、
外部咨询委员会以及试点和可行性审查委员会。
总之,行政部门将作为VOKC的协调中心。其目标是
努力为本地和更大范围内的肾脏研究人员社区提供独特的服务
和国际研究界。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAYMOND C. HARRIS其他文献
RAYMOND C. HARRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAYMOND C. HARRIS', 18)}}的其他基金
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
克隆造血对肾脏疾病进展的影响
- 批准号:
10611485 - 财政年份:2022
- 资助金额:
$ 11.66万 - 项目类别:
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
克隆造血对肾脏疾病进展的影响
- 批准号:
10419907 - 财政年份:2022
- 资助金额:
$ 11.66万 - 项目类别:
The Role of renal macrophages in recovery from renal injury
肾巨噬细胞在肾损伤恢复中的作用
- 批准号:
10194467 - 财政年份:2013
- 资助金额:
$ 11.66万 - 项目类别:
The Role of renal macrophages in recovery from renal injury
肾巨噬细胞在肾损伤恢复中的作用
- 批准号:
9765295 - 财政年份:2013
- 资助金额:
$ 11.66万 - 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
- 批准号:
8504287 - 财政年份:2013
- 资助金额:
$ 11.66万 - 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
- 批准号:
8713987 - 财政年份:2013
- 资助金额:
$ 11.66万 - 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
- 批准号:
9284449 - 财政年份:2013
- 资助金额:
$ 11.66万 - 项目类别:
Role of the innate immune system in acute kidney injury
先天免疫系统在急性肾损伤中的作用
- 批准号:
10655797 - 财政年份:2013
- 资助金额:
$ 11.66万 - 项目类别:
相似海外基金
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
HEALing LB3P:分析生物力学、生物和行为表型
- 批准号:
9897963 - 财政年份:2019
- 资助金额:
$ 11.66万 - 项目类别:
MCCTR/UMMC Year4 N3C Grant Initiative
MCCTR/UMMC Year4 N3C 资助计划
- 批准号:
10887860 - 财政年份:2016
- 资助金额:
$ 11.66万 - 项目类别:
Mississippi Center for Clinical and Translational Research
密西西比临床和转化研究中心
- 批准号:
10281515 - 财政年份:2016
- 资助金额:
$ 11.66万 - 项目类别:
Mississippi Center for Clinical and Translational Research
密西西比临床和转化研究中心
- 批准号:
10472628 - 财政年份:2016
- 资助金额:
$ 11.66万 - 项目类别: